跳至主要内容
临床试验/NCT00873067
NCT00873067已完成3 期

Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation

Hospital Clinic of Barcelona2 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
142
试验地点
2
主要终点
Freedom from atrial arrhythmias without antiarrhythmic drugs

研究概览

简要总结

The aim of this study is to evaluate whether performing complex fractionated atrial electrograms ablation improves outcomes in persistent or atrial fibrillation ablation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with persistent (more than 7 days, or less than 7 days needing pharmacologic or electric cardioversion)
  • Presence of atrial fibrillation at the beginning of the procedure

排除标准

  • Hypo or hyperthyroidism
  • Persistent long-lasting or non-defined duration atrial fibrillation
  • Hypertrophic myocardiopathy
  • Implantable defibrillation or pacemaker implanted
  • Moderate or severe mitral valve disease or mitral prosthetic valve
  • Ejection fraction less than 30%
  • Left atrial anteroposterior diameter more than 50 mm.
  • Previous atrial fibrillation ablation
  • Contraindication to anticoagulation
  • Left atrium thrombus
  • Current infective disease or sepsis
  • Pregnant women
  • Current unstable angor
  • Acute myocardial infarction in last 3 months
  • Atrial fibrillation secondary to ionic disturbance, thyroids disease or secondary to any other reversible or non cardiovascular disease
  • Reduced expectancy of life (less than 12 months)
  • Patient participating in another clinical study that investigates a drug or device
  • Psychologically unstable patient or denies to give informed consent
  • Any cause that contraindicate ablation procedure or antiarrhythmic drug

结局指标

主要结局

Freedom from atrial arrhythmias without antiarrhythmic drugs

时间窗: 1-year follow-up

次要结局

  • Freedom from atypical atria flutter(1-year follow-up)
  • Freedom form atrial arrhythmias with or without antiarrhythmic drugs(1-year follow-up)
  • Presence of any complications in the acute phase or during follow-up(1-year follow-up)
  • Increase in radioscopy time and radiofrequency application time(1-year follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Josep Lluis Mont Girbau

Head of the Arrhythmia Unit

Hospital Clinic of Barcelona

研究点 (2)

Loading locations...

相似试验